Related Experiment Video
Updated: Sep 5, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct
1The Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA. Lundberg@wi.mit.edu
Abstract:
The retinoblastoma protein (pRb) acts to constrain the G1-S transition in mammalian cells. Phosphorylation of pRb in G1 inactivates its growth-inhibitory function, allowing for cell cycle progression. Although several cyclins and associated cyclin-dependent kinases (cdks) have been implicated in pRb phosphorylation, the precise mechanism by which pRb is phosphorylated in vivo remains unclear. By inhibiting selectively either cdk4/6 or cdk2, we show that endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb only partially, a process that is likely to be completed by cyclin E-cdk2 complexes. Furthermore, cyclin E-cdk2 is unable to phosphorylate pRb in the absence of prior phosphorylation by cyclin D-cdk4/6 complexes. Complete phosphorylation of pRb, inactivation of E2F binding, and activation of E2F transcription occur only after sequential action of at least two distinct G1 cyclin kinase complexes.
Insights
Cell cycle progression relies on retinoblastoma protein (pRb) phosphorylation. Sequential action of cyclin D-cdk4/6 and cyclin E-cdk2 complexes fully inactivates pRb, enabling cell division.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The retinoblastoma protein (pRb) is a key regulator of the G1-S phase transition in mammalian cell cycle.
- Phosphorylation of pRb inactivates its growth-suppressive function, permitting cell cycle advancement.
- The exact in vivo mechanism of pRb phosphorylation by various cyclins and cyclin-dependent kinases (cdks) remains incompletely understood.
Purpose of the Study:
- To elucidate the sequential mechanism of retinoblastoma protein (pRb) phosphorylation in vivo.
- To determine the roles of distinct G1 cyclin-cdk complexes in pRb regulation.
Main Methods:
- Selective inhibition of cyclin-dependent kinase 4/6 (cdk4/6) and cyclin-dependent kinase 2 (cdk2) in mammalian cells.
- Analysis of endogenous D-type cyclins, cyclin E, and their associated cdk complexes' activity on pRb phosphorylation.
- Assessment of E2F binding inactivation and E2F transcription activation.
Main Results:
- Cyclin D-cdk4/6 complexes partially phosphorylate pRb.
- Cyclin E-cdk2 complexes complete pRb phosphorylation, but only after initial cyclin D-cdk4/6 activity.
- Sequential phosphorylation by both cyclin D-cdk4/6 and cyclin E-cdk2 is required for full pRb inactivation and E2F-mediated transcription activation.
Conclusions:
- The cell cycle G1-S transition is regulated by a sequential phosphorylation cascade involving at least two distinct G1 cyclin kinase complexes.
- Cyclin D-cdk4/6 initiates pRb phosphorylation, which is subsequently completed by cyclin E-cdk2.
- This stepwise mechanism ensures proper cell cycle progression and regulation of E2F-dependent gene expression.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Anaphase Promoting Complex
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity